SNCA and Parkinson disease: Minimally toxic dose of LPS and α-synuclein oligomer elicit synergistic dopaminergic neurodegeneration through microglial NOX2 activation34, and the present study demonstrated that overexpression of α-synuclein also predisposes SNCA mice to gut inflammation, motor activity impairment and PD development.